• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DAVOL INC., SUB. C.R. BARD, INC. VENTRALIGHT ST MESH; SURGICAL MESH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DAVOL INC., SUB. C.R. BARD, INC. VENTRALIGHT ST MESH; SURGICAL MESH Back to Search Results
Catalog Number 5954810
Medical Device Problem Codes Defective Device (2588); Patient Device Interaction Problem (4001)
Health Effect - Clinical Codes Purulent Discharge (1812); Necrosis (1971); Seroma (2069); Insufficient Information (4580)
Date of Event 12/17/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
No conclusions can be made.The patient's attorney alleges adverse patient outcome associated with the hernia mesh used to treat the patient.The patient's attorney alleges that the patient had subsequent surgical intervention; however, no details have been provided.No lot number has been provided; therefore, a review of the manufacturing records is not possible.Should additional information be provided, a supplemental emdr will be submitted.
 
Event or Problem Description
Attorney alleges that the patient underwent surgery for implant of an unspecified bard/davol ventralight st on (b)(6) 2018.As reported, the patient is making a claim for an adverse patient outcome against the ventralight st.It is alleged that the patient had subsequent surgical intervention due to the hernia mesh device.Attorney alleges that the patient experienced emotional distress and the device was defective.
 
Event or Problem Description
Attorney alleges that the patient underwent surgery for implant of an unspecified bard/davol ventralight st on (b)(6) 2018.As reported, the patient is making a claim for an adverse patient outcome against the ventralight st.It is alleged that the patient had subsequent surgical intervention due to the hernia mesh device.Attorney alleges that the patient experienced emotional distress and the device was defective.Addendum per additional information provided: (b)(6) 2009 - patient was diagnosed with recurrent incisional prepubic hernia thereby underwent open repair with implant of ventralex mesh (device #1).Per operative notes, ¿hernia sac was dissected, and a piece of ventralex mesh (device #1) was inserted into the abdominal cavity and secured using sutures.¿ (b)(6) 2010 - patient was diagnosed with incarcerated strangulated ventral incisional prepubic hernia and small bowel obstruction thereby underwent repair with mesh explant.Per operative notes, ¿dissected the hernia sac and there was ascitic fluid in abdominal cavity.The small bowel had protruded through this area.The previous ventralex mesh (device #1) was dissected out and the incorporated synthetic mesh was left in place.A synthetic mesh was then sutured circumferentially.(b)(6) 2011 - patient underwent exploratory laparotomy, closure of abdominal wound, exploration of scar and myomectomy.(b)(6) 2012 - patient underwent complex ventral hernia repair with removal of wadded up and protruding synthetic mesh.(b)(6) 2018 - patient was diagnosed with symptomatic complex ventral incisional hernia thereby underwent open repair with implant of ventralight st mesh (device #2).Per operative notes, ¿there were multiple defects, one by the umbilicus and several others had combination of small intestine and colon within sacs.A large fascial defect right above symphysis pubis.The hernia sacs were excised and a ventralight st mesh (device #2) was secured to undersurface of abdominal wall using sutures.¿ (b)(6) 2018 - patient was diagnosed with draining subcutaneous lower midline wound thereby underwent exploration and placed wound vac.Per operative notes, ¿the draining sinus opening was getting into complex subcutaneous wound.This all-above fascial level.There was no infected fluid it was more consistent with fatty necrosis.Very small amount of suture material was removed.A larger subcutaneous seroma in left vulva area was aspirated through open wound."" attorney alleges that the patient had adhesions, bowel obstruction, mesh migration, mesh shrinkage, pain, hernia recurrence, protruding mesh and balled mesh.
 
Additional Manufacturer Narrative
No conclusions can be made.The patient's attorney alleges adverse patient outcome associated with the hernia mesh used to treat the patient.The patient's attorney alleges that the patient had subsequent surgical intervention; however, no details have been provided.No lot number has been provided; therefore, a review of the manufacturing records is not possible.Addendum: h11: this supplemental emdr is submitted to document additional information provided and to correct the patient id.Based on the additional information received, there is no change to initial determination, no conclusions can be made.Per medical records review, about 2 months post implant of ventralight st mesh, patient was diagnosed with seroma, purulent drainage and necrosis thereby underwent repair.The instructions-for-use supplied with the device list seroma as possible complications.A review of the manufacturing records was performed and found that the lot was manufactured to specification.Note, the manufacturing date (15-feb-2018) is considered to be a best estimate.This supplemental emdr represents the bard/davol ventralight st mesh (device #2).Additional supplemental emdr was submitted to represent the bard/davol mesh ¿ ventralex (device #1).Note: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENTRALIGHT ST MESH
Common Device Name
SURGICAL MESH
Manufacturer (Section D)
DAVOL INC., SUB. C.R. BARD, INC.
100 crossings blvd.
warwick RI 02886
Manufacturer (Section G)
BARD SHANNON LIMITED 3005636544
san geronimo industrial park
lot #1, road #3, km 79.7
humacao PR 00791
Manufacturer Contact
andrew topoulos
100 crossings blvd.
warwick, RI 02886
4018258495
MDR Report Key12291211
Report Number1213643-2021-06690
Device Sequence Number3165432
Product Code FTL
UDI-Device Identifier00801741031687
UDI-Public(01)00801741031687(17)200528(10)HUCP2512
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
K101851
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Reporter Type Manufacturer
Report Source Other,Consumer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 04/03/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date05/28/2020
Device Catalogue Number5954810
Device Lot NumberHUCP2512
Was Device Available for Evaluation? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 08/02/2021
Supplement Date Received by Manufacturer03/17/2025
Initial Report FDA Received Date08/06/2021
Supplement Report FDA Received Date04/03/2025
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured02/15/2018
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age41 YR
Patient SexFemale
Patient Weight106 KG
-
-